Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Roche Holdings ADR RHHBY

Healthcare
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue... see more

Recent & Breaking News (OTCQX:RHHBY)

Companies Chasing Gold Nugget of Immuno-Oncology Like Never Before

Accesswire June 26, 2014

Investing in the Best Canadian Biotech Stocks

Equities.com June 23, 2014

How the Lack of R&D at Big Pharma Is Boosting Small Biotechs

Equities.com June 14, 2014

Biotech Investors Need to Focus on Catalysts

Equities.com June 11, 2014

Health Canada Approves Roche's HPV Test for First-Line Primary Screening of Cervical Cancer and Roche Launches New Cytology Test to Provide the Most Comprehensive Portfolio for Cervical Cancer Screening

Canada NewsWire June 10, 2014

Ventana Medical Systems, Inc. and MedImmune collaborate to develop a custom PD-L1 Assay for immunotherapy clinical trials

PR Newswire June 4, 2014

Investigational Immunotherapy Anti-PDL1 (MPDL3280A) Shrank Tumors in 43 Percent of People with a Specific Type of Metastatic Bladder Cancer in a Genentech Study

Business Wire May 31, 2014

Ventana Companion Diagnostics CAP/CLIA lab launches new Robust Prototype Assays

PR Newswire May 21, 2014

Roche Diagnostics recognizes Pathology, Inc as Roche Molecular Center of Excellence

PR Newswire May 20, 2014

Ventana launches new software platform for enhanced pathology education

PR Newswire May 19, 2014

Exosomes Common Link in Cancer Drug Development

Accesswire May 15, 2014

Genentech to Present New Data on 27 Different Medicines at ASCO

Business Wire May 14, 2014

OTC Markets Group Announces First Quarter 2014 Performance of OTCM ADR Index

PR Newswire April 28, 2014

FDA Approves Roche's HPV Test for First-Line Primary Screening for Cervical Cancer

PR Newswire April 24, 2014

BNY Mellon and OTC Markets Group Launch OTCQX® ADR 30 Index, Powered by BNY Mellon DR Indices(SM)

PR Newswire April 9, 2014

Ventana signs companion diagnostic agreement with international biotech for antibody drug conjugate program

PR Newswire April 3, 2014

CollabRx: Making Sense of the Complex Cancer Market

Accesswire April 1, 2014

From Lab Bench to Bedside: David Lowe Brings Common Sense to Neuroscience Investing

Equities.com March 31, 2014

Ventana supports World Health Organization's global classification of haematopoietic and lymphoid cancers

PR Newswire March 27, 2014

Xenon and Genentech Establish New Pain Discovery Collaboration

Canada NewsWire March 26, 2014